Loading
Life sciences · Review
Health Care & Global Health · September 15, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Review.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Introduction: The age of menarche may reflect early patterns of metabolic risk and has been linked to obesity, diabetes, hypertension, and cardiovascular disease in later stages. Objective: To compare cardiometabolic risk in adolescent and adult women with early, normal, and late menarche using a systematic review. Methodology: A systematic search was conducted in MEDLINE/PubMed and Scopus, following PRISMA 2020 guidelines. Observational, cohort, cross-sectional, case-control, population-based, and genetic studies published between 2021 and 2026 that assessed the age of menarche in relation to obesity, metabolic syndrome, type 2 diabetes mellitus, insulin resistance, hypertension, dyslipidemia, or cardiovascular disease were included. Selection was performed by two independent reviewers using Rayyan; discrepancies were resolved by consensus or a third reviewer. Methodological quality was assessed using NHLBI tools. Thirty-six studies were included for narrative synthesis. The protocol was registered in PROSPERO with the code CRD420261301527. Results: Most studies presented good or fair methodological quality. Early menarche was associated with a higher risk of general and abdominal obesity, metabolic syndrome, hypertension, dyslipidemia, insulin resistance, and type 2 diabetes mellitus. The association was more consistent for adiposity and metabolic syndrome; glycemic and cardiovascular outcomes showed greater heterogeneity. Some associations were attenuated after adjusting for body mass index, suggesting a mediating role of adiposity. Several studies identified nonlinear patterns, with a higher risk also associated with late menarche. Conclusions: Early menarche appears to be an early clinical marker of cardiometabolic susceptibility. Prospective cohorts are needed to clarify causality, mediators, and population cut-off points. Keywords: Menarche; Metabolic Syndrome; Cardiovascular Diseases; Metabolic Diseases (Source: MeSH, NLM).